What is Stryker's stock-based comp?

Stryker (SYK) reported stock-based comp of $87M in Q1 2026.

How has Stryker's stock-based comp changed year-over-year?

Stryker's stock-based comp increased by 3.6% year-over-year, from $84M to $87M.

What is the long-term trend for Stryker's stock-based comp?

Over 4 years (2021 to 2025), Stryker's stock-based comp has grown at a 9.2% compound annual growth rate (CAGR), from $171M to $243M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Stryker SYK Stock-Based Comp

Stock-Based Comp at other companies

Baxter InternationalBAX

$10M0.0%

Johnson & JohnsonJNJ

$300M+4.2%

AxogenAXGN

$6.84M+135%

CONMEDCNMD

$5.5M-60.3%

Merit Medical SystemsMMSI

$8.96M-1.3%

Orthofix Medical Inc.OFIX

$6.53M+1.0%

Other financials

Income statement

See full

Revenue$6.0B+2.6%

Gross profit$3.8B+1.8%

Operating income$936.0M+11.8%

Net income$745.0M+13.9%

EPS (diluted)$1.93+14.2%

Balance sheet

See full

Cash & equivalents$2.9B+24.1%

Total debt$14.4B-15.1%

Total assets$46.3B+0.6%

Cash flow

See full

Operating cash flow$581.0M+132%

CapEx$166.0M+35.0%

Free cash flow$415.0M+227%

Valuation

See full

Market cap$127.55B-13.6%

Enterprise value$139.05B-14.2%

P/E38.2×-12.4×

P/S5.1×-1.2×

Profitability

See full

Gross margin63.8%-0.1pp

Operating margin19.7%+4.4pp

Net margin13.2%+0.9pp

FCF margin18.1%+2.7pp

Returns & leverage

See full

Return on equity32.8%—

Debt / equity0.8×—

Current ratio2.1×+0.5×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stryker's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stryker's stock-based comp?: Stryker (SYK) reported stock-based comp of $87M in Q1 2026.
How has Stryker's stock-based comp changed year-over-year?: Stryker's stock-based comp increased by 3.6% year-over-year, from $84M to $87M.
What is the long-term trend for Stryker's stock-based comp?: Over 4 years (2021 to 2025), Stryker's stock-based comp has grown at a 9.2% compound annual growth rate (CAGR), from $171M to $243M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.